New Imaging Method Mapped Cancer Antibody Delivery
Researchers developed a way to visualize how well antibody drugs reach human tumor tissues.
Updated on Oct. 6, 2026 in Cancer
Live Poll
Should medical diagnostics prioritize rapid automated screening over traditional microscopic testing methods?
Scientists have validated a high-throughput fluorescence imaging method to track the distribution of the drug panitumumab-IRDye800CW in patient tissue samples. This new approach offers a clearer look at how effectively these treatments navigate the complex, heterogeneous environments of human tumors.
Why it matters
Understanding drug delivery is vital for improving cancer therapy efficacy, as significant variations between patients can impact treatment success. Validating these measurements allows researchers to better quantify how antibody drugs penetrate cancerous sites versus healthy tissue.
In a study of 946 formalin-fixed paraffin-embedded (FFPE) blocks from 17 patients, researchers used near-infrared fluorescence imaging to assess antibody delivery. The method showed a 0.73 correlation at the section level, though it was noted that decalcification reduced fluorescence intensity.
The details
The method utilizes near-infrared fluorescence to track panitumumab-IRDye800CW, with imaging resolutions ranging from 21 to 337 micrometers per pixel. By comparing macroscopic imaging with microscopy validation, the team confirmed that fluorescence intensity can effectively distinguish cancer-positive tissue. The process reveals that drug distribution is highly inconsistent both within a single tumor and across different patients.
Timeline
August 12, 2020: Clinical trial NCT#04511078 was first posted.
July 14, 2023: Clinical trial NCT#05945875 was first posted.
Health Landscape
This development aligns with the broader research goals of the NCI Cancer Moonshot initiative to accelerate the development of precise, personalized cancer therapies. It marks an effort to move beyond uniform dosing by better mapping the physical barriers that prevent drugs from reaching their targets.
While this imaging method is currently a research tool, it highlights why oncologists look at the specific biology of your tumor to determine which therapies may be most effective. If you are undergoing cancer treatment, questions about how a specific drug is expected to penetrate your tumor tissue are worth discussing with your doctor.
The takeaway
This imaging technique provides a way to verify that cancer drugs are actually reaching their intended targets within the body. Patients should remember that treatment planning is increasingly personalized based on how specific drugs interact with the unique structure of their tumor.
Further reading
For more on advancements in how tumors are analyzed and targeted, see our Cancer section.
More information
View the study details via the clinical trial registration information.
Source note: This article includes information reported by Nature.
Live Poll
Should medical diagnostics prioritize rapid automated screening over traditional microscopic testing methods?
